Difference between revisions of "B-cell CLL/lymphoma 2"
Jump to navigation
Jump to search
(create) |
|||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
[[Image: Follicluar lymphoma - bcl2 -- low mag.jpg |thumb| BCL2 expression in a follicular lymphoma.]] | [[Image: Follicluar lymphoma - bcl2 -- low mag.jpg |thumb| BCL2 expression in a follicular lymphoma.]] | ||
[[Image: Follicular lymphoma - control bcl2 -- low mag.jpg |thumb| Normal BCL2 staining in a lymph node.]] | [[Image: Follicular lymphoma - control bcl2 -- low mag.jpg |thumb| Normal BCL2 staining in a lymph node.]] | ||
'''B-cell CLL/lymphoma 2''', abbreviated '''BCL2''',<ref>{{ | '''B-cell CLL/lymphoma 2''', officially it is abbreviated '''BCL2''',<ref>{{OMIM|151430}}</ref> in an [[oncogene]] that was described in the context of [[CLL]]. It is expressed in other [[small cell lymphomas]]. | ||
Commonly used abbreviations include ''bcl-2'' and ''BCL-2''. | |||
==See also== | ==See also== | ||
*[[Lymphoma]]. | *[[Lymphoma]]. | ||
*[[Reactive follicular hyperplasia]]. | |||
*[[Immunohistochemistry]]. | *[[Immunohistochemistry]]. | ||
*[[BCL6]]. | |||
==References== | ==References== | ||
Latest revision as of 15:50, 26 April 2022
B-cell CLL/lymphoma 2, officially it is abbreviated BCL2,[1] in an oncogene that was described in the context of CLL. It is expressed in other small cell lymphomas.
Commonly used abbreviations include bcl-2 and BCL-2.